Novo, Hims & Hers said to be eyeing a partnership to sell...

2026-03-07 08:19:03 ET More on Hims & Hers Health, Novo Nordisk CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry Hims & Hers Health: Leaving GLP-1s Behind Pricing Pressure And Panic: What The Market May Be Missing In Novo Nordisk Most and least shorted mid-to mega-cap healthcare stocks in February Hims & Hers back in red as FDA doubles down on GLP-1 compounders Read the full article on Seeking Alpha For further details see: Novo, Hims & Hers said to be eyeing a partnership to sell obesity drugs